Kyowa Kirin International

Kyowa Kirin is a Japan-based global specialty pharmaceutical company delivering life-changing value for people impacted by under-diagnosed and under-served diseases. We develop innovative medicines and treatments for people living with rare diseases in bone and mineral disease, challenging blood conditions and blood cancers. We have invested in drug discovery and biotechnology innovation for more than 75 years, and right now, we are working to engineer the next generation of antibodies and cell and gene therapies. We bring humility, creativity and a relentless passion to achieve our purpose: to make people smile.